GLP-1 (Glucagon-Like Peptide-1) as distributed by Peptides Lab UK is not intended for, and must not be used for, human consumption, medical treatment, self-administration, veterinary applications, or any use outside of a controlled laboratory environment
Exposure to Toxins and Pollution: Our environment matters too
PubMed Bkdal, T.A., Borregaard, J., Donsmark, M., Breitschaft, A., Sndergaard, F.L., & Jrgensen, S
88 A large multi-institutional study of patients with spontaneous intracerebral hemorrhage showed that those taking these drugs had significantly lower death rates during follow-up, as well as fewer rebleeding episodes, seizures, and cases of hydrocephalus
Retrieved from
After some time in the Department of Medical Anatomy at the University of Copenhagen, rskov joined Novo Nordisk in 2007 where she became involved in developing new GLP-1 based drugs